News & Events

The Max Delbrück Center wants to shape the future of medicine through innovation. But turning basic research into marketable products requires gaps to be bridged. This is achieved by the Technology Transfer Office – through funding schemes such as BOOST and Pre-GoBio. The winning projects for 2023 have now been selected.

It takes great patience and perseverance to turn research findings into new technologies or therapies. The Helmholtz Initiative and Networking Fund gives financial support to “pathfinder projects” that are particularly promising. Researchers at the Max Delbrück Center have now won grants for three projects.

Peran Hayes, who took part in the "Back to the Roots Program", teaches students how to build their own microscope. For „We at the MDC”, he explains how a university course in Ghana has transformed into a West-African research network.

Partners in industry and research are aiming to optimise the diagnosis of cancer and other diseases with a novel microscopy technique. The QEED research project has been allocated a two-figure million sum in funding. ECRC scientist Hendrik Bartolomaeus is a member of the consortium.

Berlin-based research project MSTARS is entering its second round. Matthias Selbach and Fabian Coscia explain how the Max Delbrück Center is contributing, why the collaboration with Charité is so important, and how studying proteins in cells can help identify the best therapy for a patient.

At the “Hauptstadtforum” of the MINT-EC school excellence network, students had the opportunity to learn about the latest research at the Max Delbrück Center, including how to use machine learning to decode data and enhance immune cells to protect from COVID-19.

A team of scientists led by Martin Janz and Klaus Rajewsky at the Max Delbrück Center has successfully generated genetically defined mouse models for two subtypes of multiple myeloma. These models will contribute to a better understanding of how the disease develops in humans. The team has now published their findings in the journal PNAS.

Employees of the Max Delbrück Center and the Experimental and Clinical Research Center are mourning the loss of Gisela Krebs, who has passed away at the age of 91. Since 2015, her foundation has been supporting muscle desease research.